Home - Products - Others - Other Targets - Ferulamide

Ferulamide

CAS No. 61012-31-5

Ferulamide( 4-Hydroxy-3-methoxycinnamide )

Catalog No. M29143 CAS No. 61012-31-5

Ferulamide, a Ferulic acid derivative, shows potent inhibitory activity against arachidonic acid-induced platelet aggregation.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	410	Get Quote
10MG	602	Get Quote
25MG	945	Get Quote
50MG	1278	Get Quote
100MG	1728	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Ferulamide
Note

Research use only, not for human use.
Brief Description

Ferulamide, a Ferulic acid derivative, shows potent inhibitory activity against arachidonic acid-induced platelet aggregation.
Description

Ferulamide, a Ferulic acid derivative, shows potent inhibitory activity against arachidonic acid-induced platelet aggregation.(In Vitro):A series of Ferulamide derivatives were prepared and evaluated for their anti-platelet activities. Some of these compounds showed potent inhibitory activity against arachidonic acid-induced platelet aggregation. Their structure-activity relationships are also discussed.
In Vitro

——
In Vivo

——
Synonyms

4-Hydroxy-3-methoxycinnamide
Pathway

Others
Target

Other Targets
Recptor

——
Research Area

——
Indication

——

Chemical Information

CAS Number

61012-31-5
Formula Weight

193.202
Molecular Formula

C10H11NO3
Purity

>98% (HPLC)
Solubility

——
SMILES

COc(cc(/C=C/C(N)=O)cc1)c1O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Verdiperstat

Verdiperstat (AZD-3241) is a potent, selective, reversible, orally active myeloperoxidase (MPO) inhibitor with IC50 of 630 nM, >14-fold selectivity over thyroid peroxidase (TPO).
BCPA

BCPA is a non-cytotoxic Pin1 modulator.BCPA modulates osteoclast activation and attenuates the reduction of Pin1 protein, thereby inhibiting RANKL-induced receptor activators of osteoclastogenesis.BCPA is used in the study of osteoporosis.
(2S,3S)-3-Hydroxy-2-...

(2S,3S)-3-Hydroxy-2-methyl-3-phenylpropanoic acid is a chemical synthesis intermediate.

Sign In Join Free